Explanations for such disagreement may be searched in a relatively low number of participants in the group of deceased patients with COVID-19, in presence of comorbidities that significantly influenced the results of association studies, as well as in differences in transcriptional and posttranscriptional regulation of the expression of ACE1 between a disease and healthy condition. This evidence concerns the gene ACE and COVID-19.